ERBB2 and breast carcinoma: For example, similarly to the publicly available breast cancer dataset, we observed a decrease in HLA-E expression in the proprietary ER + /HER2- breast tumors compared to the normal adjacent to tumor tissue, and an increased infiltration of NK cells in four out of five patients (Fig. 4).